Pediatric Infectious Diseases
CDC: Worrisome Spike in Younger Teens’ COVID Hospitalizations
Younger teens may not be as likely to have severe COVID-19 as adults, but their hospitalization rates spiked early this
June 4, 2021
Younger teens may not be as likely to have severe COVID-19 as adults, but their hospitalization rates spiked early this
Two phase 3, placebo-controlled studies suggest the oral Janus kinase (JAK) inhibitor upadacitinib is effective for moderate-to-severe atopic dermatitis (AD),
Since the early reports of a severe COVID-19–related condition called multisystem inflammatory syndrome in children a few months into the
Copyright © 2024, A4M. All trademarks, registered or unregistered, are the property of their respective owners.
